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Introduction

Abstract
Some species of mushrooms in the genus Amanita are extremely poisonous and frequently fatal to mammals including humans and dogs. Their extreme toxicity is due to amatoxins such as α- and β-amanitin. Amanita mushrooms also
biosynthesize a chemically related group of toxins, the phallotoxins, such as phalloidin. The amatoxins and phallotoxins (collectively known as the Amanita toxins) are bicyclic
octa- and heptapeptides, respectively. Both contain an unusual Trp-Cys cross-bridge known as tryptathionine. We have
shown that, in Amanita bisporigera, the amatoxins and phallotoxins are synthesized as proproteins on ribosomes and not by
nonribosomal peptide synthetases. The proproteins are 34–35
amino acids in length and have no predicted signal peptides.
The genes for α-amanitin (AMA1) and phallacidin (PHA1) are
members of a large family of related genes, characterized by
highly conserved amino acid sequences flanking a hypervariable “toxin” region. The toxin regions are flanked by invariant
proline (Pro) residues. An enzyme that could cleave the proprotein of phalloidin was purified from the phalloidin-producing lawn mushroom Conocybe apala. The enzyme is a serine protease in the prolyl oligopeptidase (POP) subfamily. The
same enzyme cuts at both Pro residues to release the linear
hepta- or octapeptide.

Certain species in the genus Amanita account for
more than 90% of the fatal mushroom poisonings
worldwide. Amatoxins such as α-amanitin (Figure 1A)
are the poisonous compounds in species of Amanita sect,
Phalloideae. The human LD50 for α-amanitin is ~0.1 mg/
kg, and one mushroom can contain a fatal dose of 10–12
mg.1 There are several forms of amatoxins, which differ
in their pattern of hydroxylation and/or containing Asn
instead of Asp. Amatoxins are also made by several species of mushroom in other unrelated genera.
Amatoxins survive the human digestive tract and enter liver cells, where they inhibit RNA polymerase II.2
Without prompt intervention, amatoxins cause irreversible liver failure and death in 3–7 days. Liver transplants
are often the only treatment option if more than 48 h has
elapsed since ingestion.
Species of Amanita that make amatoxins also make a
related family of cyclic peptides known as phallotoxins,
such as phalloidin and phallacidin (Figure 1B). Phallotoxins are also made by Conocybe apala (=C. albipes or C.
lactea).3 The phallotoxins contain seven instead of eight
amino acids, a sulfide (thioether) instead of a sulfox-

Keywords: amanitin, halloidin, phallacidin, prolyl oligopeptidase, Conocybe, Amanita
659

660

W a l t o n , H a l l e n -A d a m s , & L u o

in

P e p t i d e S c i e n c e 94 (2010)

Figure 1. A: Structure of α-amanitin (an amatoxin). B: Structure of phallacidin (a phallotoxin). All amino acids have the L configuration except D-hydroxyAsp in phallacidin (D-Thr in phalloidin).

ide in the cross-bridge between Trp and Cys, and one
amino acid with the D configuration. Phallotoxins are
toxic to mammals if injected but are not absorbed by the
digestive tract.1 Phallotoxins stabilize F-actin, and fluorescent conjugates of phalloidin are commonly used to
study the actin cytoskeleton.
We recently showed that the amatoxins and phallotoxins are biosynthesized on ribosomes, and not, like all
other known fungal cyclic peptides, by nonribosomal
peptide synthetases.4 The genes were discovered by genomic survey sequencing using 454 pyrosequencing of
Amanita bisporigera, the “destroying angel” mushroom
(see Figure 2). In addition to AMA1 (for α-amanitin) and
PHA1 (for phallacidin), the genome of A. bisporigera contains a large family of related genes, which we call the
MSDIN family. In all members of this family, the proproteins are ~34–39 amino acids in length and lack predicted signal peptides. The regions of these proproteins
that contain the amino acid sequences found in the mature toxins are 6–10 amino acids in length and are hypervariable compared to the surrounding amino acid
sequences (see Figure 3). These compounds are among
the smallest known ribosomally synthesized cyclic peptides. In all family members, a proline (Pro) residue is
always the immediate upstream amino acid and also
the last amino acid in the predicted hypervariable regions. All known amatoxins and phallotoxins and all
predicted MSDIN peptides contain at least one Pro residue, but only the amatoxins and phallotoxins contain
Trp and Cys, and so only these subfamily members can
form tryptathionine. Several monocyclic hexa- and decapeptides have been isolated from A. phalloides.1 All 20
proteinogenic amino acids have been found at least once
in one of the MSDIN family members of A. bisporigera.
We have also used PCR to amplify members of the MS-

DIN family from A. phalloides (the death cap mushroom)
and A.ocreata.4
Processing of the Amanita Toxins
Following translation, subsequent necessary steps
in Amanita toxin biosynthesis include proteolytic excision, cyclization, hydroxylation, Trp-Cys (tryptathionine) cross-linking, and, in the case of the phallotoxins, epimerization of one amino acid. These steps do not
necessarily occur in that order. Amanita toxin biosynthesis might also require genes encoding proteins for
export and regulation, as is often seen for other fungal
secondary metabolites (e.g., Reference 5). Cyclization
might occur before or after tryptathionine biosynthesis.

Figure 2. Amanita bisporigera collected in Michigan in 2009.
This deadly white mushroom, known as the “destroying angel,” is a native of North America and biosynthesizes amatoxins and phallotoxins.
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Figure 3. WebLogo alignment of 15 members of the “MSDIN”
family (named for the first five highly conserved amino acids).
The height of the amino acid at each position represents its degree of conservation. The MSDIN family encodes the amatoxins and phallotoxins and is also predicted to encode a variety
of unknown peptides within the hypervariable central region
(amino acids 11–20), which is 6–10 amino acids in length (Xs
have been inserted in the hypervariable regions of less than 10
amino acids to emphasize the conservation of the carboxy terminus of the MSDIN peptides). As defined here, the “hypervariable” region includes the carboxy-terminal Pro, which is
completely conserved in the MSDIN family as well as being a
constituent of the mature toxins. Based on cDNA sequences,
the M (Met) of MSDIN is the translational start codon. Amino
acids 35–39 are not shown, because there is an intron (experimentally established for AMA1 and PHA1; deduced for the
others) that interrupts the third to the last codon. (Originally
published in Luo et al. J Biol Chem 284 [2009], pp. 18070–18077.
Copyright © the American Society for Biochemistry and Molecular Biology.)

It is currently difficult to address the biochemistry
of the post-translational processing steps, because the
uniqueness of the Amanita system means that other ribosomal peptide biosynthetic systems, such as cyclotides
or patellamides, cannot serve as precedents. Also, the
complete genome of any toxin-producing, Amanita species is not available.
A common feature of fungal secondary metabolites, at least in ascomycetes and some basidiomycetes,
is clustering of the genes in the pathway. It is important to note that eukaryotic gene clustering is quite distinct from the clustering found in bacterial operons; although both types comprise 3–15 genes each separated
by 0.2–2 kb, in eukaryotic clusters each gene has its own
promoter, that is, there are no polycistronic mRNAs.
Typical fungal secondary metabolite gene clusters contain biosynthetic genes, genes for transporters (metabolite efflux carriers or pumps), and pathway-specific transcription factors that positively regulate the other genes
of the cluster.5–7 Preliminary evidence suggests that
some of the MSDIN genes are clustered with some potential biosynthetic genes (unpublished results), but our
genome survey sequence data of A. bisporigera are still
too incomplete to draw any solid conclusions.
Proteolytic Cleavage of the Proprotein
As noted earlier, the hypervariable regions of the MSDIN family have invariant flanking Pro residues (see
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Figure 3). Consideration of the known Pro-specific peptidases 8 suggested that a prolyl oligopeptidase (POP) catalyzes the initial biosynthetic step. POPs are widespread
in animals, plants, bacteria, and fungi (except, strangely,
ascomycetes) and cleave at internal Pro residues of small
proteins (<35 amino acid). A. bisporigera has two POP
genes, one of which is found only in Amanita sect. Phalloidae (Reference 4 and unpublished observations). Other
fully sequenced (toxin nonproducing) fungi including
Coprinus cinerea, Phanerochaete chrysosporium, and Laccaria
bicolor appear to each have a single POP gene.
To determine the enzyme that was responsible for the
proteolytic processing of the Amanita toxins, it was purified from mushroom extracts. Amanita species themselves are transient in availability (they cannot be cultured in the laboratory) and therefore we used Conocybe
apala as the starting material, a mushroom which grows
abundantly in well-watered lawns of the Michigan State
University campus (see Figure 4). It is possible to collect
kilogram quantities of C. apala in a few days. The mushrooms continue to emerge daily throughout the summer. C. apala makes phalloidin (but not amanitin)3 and
therefore must contain the enzyme (or enzymes) that
cleave the phalloidin proprotein.
Using standard protein purification methods, we
identified an enzyme from C. albipes that cleaves a synthetic phalloidin peptide.10 During the early stages of
purification, it became apparent that the cleavage enzyme was copurifying with activity against the POP
substrate Z-Gly-Pro-pNA and was inhibited by the specific POP inhibitor Z-Pro-Prolinal. The cleavage enzyme
was purified to homogeneity and subjected to mass
spectrometric peptide analysis. Combined with the full
amino acid sequence deduced from a cDNA, we identified the protein as a member of the POP family of serine
proteases.9 The pure enzyme cuts at both Pro residues
in the synthetic phalloidin peptide to release the mature
linear peptide, preferentially cutting at the Pro closer to
the carboxy terminus before cutting at the Pro closer to
the amino terminus (see Figure 5).
In regard to the mechanism of cyclization of the Amanita toxins, there are some potentially relevant precedents presented in other works in this volume. As
shown elsewhere in this volume, trypsin and other proteases are capable of making as well as breaking peptide bonds.11, 12 It is very likely that a protease or proteaselike enzyme catalyzes the cyclization of the Amanita
toxins. However, to date, no chromatographic or mass
spectrometric evidence was obtained for any cyclized
product during incubation of toxin precursors with
POP, and therefore cyclization is probably not catalyzed
by POP. In regard to the sequence of processing steps,
cyclication might occur after formation of the Trp-Cys
crossbridge (tryptathionine), because this would facilitate cyclization by bringing the N and C termini of the
nascent peptide closer together.
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Figure 5. Time course of cleavage of a synthetic phalloidin
precursor (substrate: MSDINATRLPAWLATCPCAGDD). Purified POP from C. apala was incubated with the substrate for
the indicated times. Products were separated by HPLC and
quantitated by their absorbance at 280 nm. The intermediate
was identified as MSDINATRLPAWLATCP and the product
as AWLATCP by mass spectrometry. No evidence for a carboxy-terminal intermediate (AWLATCPCAGDD) was found.
Dithiothreitol was included in the enzyme buffer to prevent
oxidation of the two Cys residues (Originally published in Luo
et al. J Biol Chem 284 [2009], pp. 18070–18077. Copyright © the
American Society for Biochemistry and Molecular Biology).

Histology of Toxin Biosynthesis
Mushrooms are multicellular organisms with many
specialized cell types. There are many examples of
mushroom toxins and many examples of chemically
specialized cell types in mushrooms.13 However, in only
a few cases, is there any direct evidence connecting the
two, that is, a specific cell type with a specific metabolite. Do the cell types that show differential staining or
morphology (consistent with a metabolic specialization of some sort) serve as the sites of toxin biosynthesis and/or storage?14 Two examples of specialized cell
types in toxic mushrooms are shown in Figure 6. The

Figure 4. A: Collecting Conocybe apala (formerly C. lactea or
C. albipes) from watered lawns on the campus of Michigan
State University. B: C. apala. The mushrooms are ~8 cm tall.
C: High magnification of secretory cells with attached liquid
droplets from a culture of C. apala established in our laboratory. The droplets are not membrane-bound and are easily
washed off. For more pictures of C. apala secretory cells, see
http://www.uoguelph.ca/~gbarron/2008/conocybe.htm
and Reference 9.

Figure 6. Examples of anatomically and biochemically specialized cells in mushrooms. A: “Inocybe sp. involved in a fatal poisoning case of a young dog. The encrusted cystidia
stand up on the gill edges.” The abundant brown circles are
basidiospores;
http://www.flickr.com/photos/cornellfungi/2829688392/ . B: Cystidia of Russula. These contain unknown insecticidal compound(s). The droplets (arrow) are not
membrane bound and the contents adhere to glass. The droplet is is ~10 μm in diameter (from Reference 15; reprinted with
permission).
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cystidia of a poisonous Inocybe species are large and
appear to be free of cytoplasm and could be the site
of storage of the toxic compounds produced by this
mushroom (Figure 6A). The mushroom Russula bella
has a specialized cell type that contains unknown metabolites toxic to insects15 (Figure 6B). Such specialized
cell types could be sites of biosynthesis and/or storage sites. C. apala, which makes phallotoxins and from
which we purified POP, also has specialized cells that
appear to be sites of biosynthesis and/or accumulation
of specialized secondary metabolites. These structures
could contain phalloidin, but to the best of our knowledge, this has not been addressed experimentally9 (Figure 4C).
Amanita Toxin Biosynthesis in Context
Small, modified, ribosomally synthesized, and biologically active peptides have been identified from
many eukaryotic and prokaryotic sources, including
bacteria, spiders, snakes, cone snails, plants, and amphibian skin.16–20 Like the Amanita toxins, these peptides
are synthesized as precursor proteins and often undergo
post-translational modifications similar to those of the
Amanita toxins, such as cyclization, hydroxylation, and
epimerization.
The cone snail toxins (conotoxins) are 12–40 amino
acids. Like the Amanita toxins, the cone snail toxins exist as gene families, the members of which have
hypervariable regions (corresponding to the amino
acids present in the mature toxins) and conserved regions found in all members.18 Conotoxins and Amanita toxins differ in several key respects. First, the Amanita toxins are smaller (7–10 amino acids vs. 12–40 for
the conotoxins).21 Second, the mature conotoxins are
at the carboxy termini of the preproproteins and are
predicted to be cleaved by a protease that cuts at basic amino acids (Arg or Lys). In contrast, the mature
Amanita toxin sequences are internal to the proprotein and are predicted to require two cleavages by one
or more Pro-specific peptidases. Third, the conotoxins
are “cyclized” not by true head-to-tail peptide bonds
but rather by multiple disulfide bonds, and the Amanita toxins do not have disulfide bonds. Therefore, we
do not predict the involvement of a protein disulfide
isomerase as has been found for cone snail toxins and
cyclotides.21, 22 However, it is not impossible that the
formation of the Trp-Cys bond in Amanita toxins is catalyzed by an unusual disulfide isomerase. Fourth, the
conotoxin preproproteins have signal peptides to direct secretion of the proprotein into the venom duct,
whereas the Amanita toxins are not secreted 23 and their
proproteins lack predicted signal peptides.
Cyclotides such as kalata B1 are 28–37 amino acids
in size.16, 20 The precursor structure contains an N-ter-
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minal signal peptide followed by a proprotein region
and a conserved “N-terminal repeat region” containing a highly conserved domain of ~20 amino acids, one
to three cyclotide domains, and a short C-terminal sequence. An Asn-endopeptidase is responsible for removing the C-terminal peptide from the proprotein and
cyclizing the peptide,24 but the protease that cuts the
N-terminus is apparently not known. The mature cyclotides are true head-to-tail cyclic peptides but are also
held in rigid conformations by multiple disulfide bonds.
The cyclotides and the Amanita toxins are both eukaryotic in origin, but differ in size, gene organization, and
method of processing, and by the absence of disulfide
bonds in the Amanita toxins.
In the recent years, a number of ribosomally encoded
cyclic peptide secondary metabolites have been described from prokaryotes.19 These include lantibiotics,
thiocillins, thiomuracins, microcins, microcyclamides,
and cyanobactins, such as patellamides, streptolysin,
and tricyclic depsipeptides. Bacterial autoinducing peptides (AIPs), which are 7–9 amino acids, mediate quorum sensing by certain human pathogenic Gram-positive bacteria.25 AIPs are posttranslationally cyclized
by the formation of a thiolactone between the carboxyl
group of the C-terminal amino acid and an internal Cys.
AIP proproteins are processed at the C-terminus by
agrB with simultaneous condensation to form the thiolactone ring.25
Lantibiotics such as nisin, subtilin, and cinnamycin, are produced by species of Lactobacillus, Streptococcus, and other bacteria. They contain 19–38 amino
acids and are characterized by the presence of lanthionine, which is formed biosynthetically by dehydration
of an Ala residue followed by intramolecular addition
of Cys.26 The lantibiotics are similar to the Amanita toxins in containing a modified, cross-linked Cys residue.
However, the Cys in the Amanita toxins is cross-linked
to a Trp residue instead of Ala as in the case of the lantibiotics. Microcin J25 is a 21-amino acid peptide cyclized between an N-terminal Gly or Cys residue and
an internal Glu or Asp residue. It is produced by E. coli;
other enterobacteria produce related peptides. Processing of the primary translation product (58 amino acids) involves cleavage of a 37-residue leader peptide
and cyclization. The maturation reaction requires ATP
for amide bond formation.27 There are no orthologs of
mcjA or mcjB in any available fungal genome, including A. bisporigera.
Patellamides and other cyanobactins are produced
by cyanobacterial symbionts of marine ascidians.19, 28,
29 Like the Amanita toxins, cyanobactins are small (eight
amino acids) and are cleaved internally from their proproteins. Unlike the Amanita toxins, the primary translation products of the cyanobactin contain two toxin
“cassettes,” each of which gives rise to an individual cyanobactin.28 The cyanobactins are post-translationally
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modified differently from the Amanita toxins, in particular, by heterocyclization. The patellamides are cleaved
from their proproteins by a subtilisinlike protease
(PatA) and cyclized by PatG.30 PatA recognizes flanking
conserved amino acids, but cleavage occurs at a Ser residue instead of Pro as in the case of the Amanita toxins.
The amino acids that are conserved up and downstream
of the hypervariable toxin region in the MSDIN family
(see Figure 3) might also serve as a recognition sequence
for cleavage by POP. PatA makes both cuts of the patellamides, like POP in the Amanita system.10 However,
compared to the action of POP on a phalloidin precursor, the activity of PatA is very slow.30 Cyclization of
patellamides does not require an additional source of
energy; it is apparently driven by coupling with the proteolytic reaction.30 Searching of all sequenced fungi, including A. bisporigera, have failed to find any orthologs
of PatA or PatG (or any of the other genes of the patellamide cluster), and so the mechanism of cyclization of
the Amanita toxins is apparently different from the case
of the cyanobactins.
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